Which peptides will the FDA propose adding to the 503A Bulks List?

As of Thu, 19 Nov 2026 13:00:42 UTC, Kalshi traders price BPC-157 (79.0%), KPV (78.0%), MOTS-c (76.0%). The market has $4K in volume and closes on Fri, 01 Oct 2027.

Updated:

Current odds

OutcomeChanceYes priceNo price
BPC-15779.0%79.0¢21.0¢
KPV78.0%78.0¢22.0¢
MOTS-c76.0%76.0¢24.0¢
Semax76.0%76.0¢24.0¢
TB-50076.0%76.0¢24.0¢
Epitalon76.0%76.0¢24.0¢
Emideltide26.0%26.0¢74.0¢

Market details

Resolution rules

Each outcome is a separate contract with its own rules. The rules for BPC-157:

If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.

Sources

Related markets

More markets like this

A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use

DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.